ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,899Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 973

$418K Total Retail Price of All Prescriptions

Rank: 218 out of 973

532 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 532 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 532 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,281 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
PRAVASTATIN SODIUM 495 428 1 22
LEVOTHYROXINE SODIUM 400 343 2 2
OMEPRAZOLE 374 315 3 5
LISINOPRIL 299 259 4 3
METFORMIN HCL 257 212 5 8
WARFARIN SODIUM 223 207 6 10
SIMVASTATIN 222 222 7 1
AMLODIPINE BESYLATE 215 203 8 7
POTASSIUM CHLORIDE 207 148 9 9
CARVEDILOL 202 202 10 27
FUROSEMIDE 199 172 11 6
HYDROCODONE-ACETAMINOPHEN 193 166 S3 12 4
LOSARTAN POTASSIUM 181 171 13 19
GABAPENTIN 157 131 14 12
HYDROCHLOROTHIAZIDE 155 155 15 11
TRIAMTERENE-HCTZ 148 95 16 51
ATORVASTATIN CALCIUM 141 123 17 15
TRAMADOL HCL 141 105 17 18
CITALOPRAM HBR 138 110 19 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 100 20 25
FENOFIBRATE 125 101 20 77
PROAIR HFA 106 76 22 54
METOPROLOL TARTRATE 101 91 23 13
ZOLPIDEM TARTRATE 100 61 24 20
FLUTICASONE PROPIONATE 98 75 25 35
BYSTOLIC 97 85 26 110
ALLOPURINOL 86 84 27 29
ROPINIROLE HCL 81 74 28 72
DONEPEZIL HCL 79 77 29 26
PREDNISONE 77 65 30 33
FLUOXETINE HCL 72 52 31 56
AZITHROMYCIN 71 62 32 47
ALENDRONATE SODIUM 69 69 33 24
FAMOTIDINE 69 51 33 61
PANTOPRAZOLE SODIUM 67 53 35 37
SERTRALINE HCL 64 54 36 21
DILTIAZEM 24HR CD 62 62 37 104
ATENOLOL 62 61 37 16
LEVOFLOXACIN 61 51 39 84
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 40 46
CLOPIDOGREL 58 44 41 44
DIGOXIN 56 56 42 32
CIPROFLOXACIN HCL 55 51 43 57
DIOVAN 54 54 44 63
CARTIA XT 52 52 45 368
METOPROLOL SUCCINATE 51 47 46 17
SYNTHROID 50 50 47 50
TAMSULOSIN HCL 50 49 47 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.